MASAB Memos
The Medical & Scientific Advisory Board (MASAB) of the National Blood Clot Alliance will be issuing periodic Medical Memos, explaining the importance of new research in the field of venous thromboembolism, or blood clots in the legs and blood clots in the lungs.
These Medical Memos will be authored by NBCA MASAB members, and appear on NBCA’s website monthly.
Access links to these individual MASAB Memos will be chronicled below.
If you have questions about any of the research work you read about in these MASAB Memos, please contact info@stoptheclot.org.
MASAB Memo #7, July 31, 2018
Is less more? Can an aspirin a day keep the blood clots away?
by Michael Streiff, MD, Professor of Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore
MASAB Memo #6, April 16, 2018
We have a pill for that! Cancer-associated thrombosis.
by Michael Streiff, MD, Professor of Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore
MASAB Memo #5, March 7, 2018
New Study Results – Clot-Busting Treatment
by Suresh Vedantham, MD, Professor of Radiology & Surgery, Mallinckrodt Institute of Radiology, Washington University, St. Louis
MASAB Medical Memo #4, January 30, 2018
Can we improve warfarin therapy by monitoring at home?
by Jack Ansell, MD, MACP, Hofstra Northwell School of Medicine, New York
MASAB Medical Memo #3, November 2, 2017
The PIONEER Trial, Three May End Up Being a Crowd
by Samuel A. Berkman, MD, FACP, Clinical Professor of Medicine, Division of Hematology-Oncology, UCLA, Los Angeles
MASAB Medical Memo #2, September 25, 2017
Should we keep the pressure on? Graduated compression stockings for prevention of post-thrombotic syndrome.
by Michael B. Streiff M.D., Associate Professor of Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore
MASAB Medical Memo #1, August 22, 2017
EINSTEIN CHOICE study on extended treatment of venous thromboembolism
by Jeffrey Weitz, MD, Henderson Regional Cancer Centre, Hamilton, Ontario